CLASS II Device recall · Reported 14 Feb 2018 · FDA Enforcement Report

Syngo.plaza systems with SW VB20A recalled

Siemens Medical Solutions USA is recalling Syngo.plaza systems with SW VB20A, distributed nationwide in the US. The recall was initiated on 23 Aug 2017 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesModel Number - 10863171, 10863172, 10863173
Quantity recalled76

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0524-2018
FDA event ID
78677
Recalling firm
Siemens Medical Solutions USA, Malvern, PA
Classification
Class II
Status
Terminated
Recall initiated
23 Aug 2017
FDA classified
5 Feb 2018
Reported
14 Feb 2018
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

23 Aug 2017Recall initiated by company
5 Feb 2018Classified by FDA+166 days
14 Feb 2018Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

When a prior study is being replaced in the workflow step, in certain scenarios (based on the Display Protocol configuration) the prior study will only be replaced in the active Workflow Step and not show in all other workflow steps. The other workflow steps will continue to show the initially loaded study.

Product as listed by the FDA

Syngo.plaza systems with SW VB20A, Model Number - 10863171, 10863172, 10863173 Product Usage: Syngo.plaza is a Picture Archiving and Communication System (PACS) intended to display, process, read, report, communicate, distribute, store and archive digital medical images. It supports the physician in diagnosis and treatment planning. Syngo.plaza also supports storage and archiving of DICOM Structured reports. In a comprehensive imaging syngo.plaza integrates Hospital/Radiology Information Systems (HIS/RIS) to enable customer specific workflows. Syngo.plaza optionally uses a variety of advanced postprocessing applications.

Where it was distributed

US Nationwide Distribution

Nationwide

Questions about this recall

Why was it recalled?

When a prior study is being replaced in the workflow step, in certain scenarios (based on the Display Protocol configuration) the prior study will only be replaced in the active Workflow Step and not show in all other workflow steps. The other workflow steps will continue to show the initially loaded study.

Which lots are affected?

Model Number - 10863171, 10863172, 10863173

Where was it sold?

US Nationwide Distribution

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Siemens Medical Solutions USA

All 796

Other Imaging Equipment recalls

All 2,336